Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Breathing training shows promise for long COVID fatigue

NCT ID NCT07397130

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether a breathing exercise using pressure biofeedback can help women with long COVID-19 improve their breathing muscle strength. 80 women who had COVID-19 and still had breathing problems took part. They did special diaphragm training for four weeks. The goal was to see if this training could make their breathing muscles stronger and help them feel better.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

80 people

The number who actually took part.

Started

Jul 2024

Finished

Oct 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Female patients treated at Persahabatan Hospital. * History of COVID-19 infection. * Attending the Pulmonology Clinic and/or the Medical Rehabilitation Clinic at Persahabatan Hospital. * Willing to participate in indirect diaphragmatic training using pressure biofeedback for four consecutive weeks. * Willing to participate as research subjects. Exclusion Criteria: * Female patients not treated at Persahabatan Hospital * No history of COVID-19 infection * Not participating in indirect diaphragmatic training using pressure biofeedback for four consecutive weeks * Presence of other pulmonary disease such as tuberculosis, chronic obstructive pulmonary disease, or asthma

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Long COVID-19 syndrome are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Rumah Sakit Umum Pusat Persahabatan

    Jakarta, DKI Jakarta, 13230, Indonesia

More trials for these conditions

Other studies related to the condition(s) this trial covers.